nodes	percent_of_prediction	percent_of_DWPC	metapath
Granisetron—CYP1A1—kidney cancer	0.366	1	CbGaD
Granisetron—CYP3A5—Temsirolimus—kidney cancer	0.0674	0.147	CbGbCtD
Granisetron—CYP1A1—Erlotinib—kidney cancer	0.0421	0.0917	CbGbCtD
Granisetron—CYP2D6—Temsirolimus—kidney cancer	0.0414	0.09	CbGbCtD
Granisetron—CYP3A4—Everolimus—kidney cancer	0.0389	0.0847	CbGbCtD
Granisetron—CYP3A4—Temsirolimus—kidney cancer	0.0263	0.0572	CbGbCtD
Granisetron—CYP3A5—Erlotinib—kidney cancer	0.0253	0.055	CbGbCtD
Granisetron—CYP3A5—Paclitaxel—kidney cancer	0.0231	0.0504	CbGbCtD
Granisetron—CYP2D6—Pazopanib—kidney cancer	0.0217	0.0473	CbGbCtD
Granisetron—CYP3A5—Sorafenib—kidney cancer	0.0206	0.0447	CbGbCtD
Granisetron—CYP3A5—Vincristine—kidney cancer	0.02	0.0434	CbGbCtD
Granisetron—CYP3A5—Sunitinib—kidney cancer	0.0167	0.0362	CbGbCtD
Granisetron—CYP2D6—Erlotinib—kidney cancer	0.0155	0.0337	CbGbCtD
Granisetron—CYP3A4—Pazopanib—kidney cancer	0.0138	0.0301	CbGbCtD
Granisetron—CYP2D6—Sorafenib—kidney cancer	0.0126	0.0274	CbGbCtD
Granisetron—CYP2D6—Vinblastine—kidney cancer	0.0124	0.0271	CbGbCtD
Granisetron—CYP3A4—Erlotinib—kidney cancer	0.00986	0.0215	CbGbCtD
Granisetron—CYP3A4—Paclitaxel—kidney cancer	0.00902	0.0196	CbGbCtD
Granisetron—CYP3A4—Sorafenib—kidney cancer	0.00801	0.0174	CbGbCtD
Granisetron—CYP3A4—Vinblastine—kidney cancer	0.00791	0.0172	CbGbCtD
Granisetron—CYP3A4—Vincristine—kidney cancer	0.00778	0.0169	CbGbCtD
Granisetron—CYP2D6—Doxorubicin—kidney cancer	0.00765	0.0166	CbGbCtD
Granisetron—CYP3A4—Sunitinib—kidney cancer	0.00649	0.0141	CbGbCtD
Granisetron—CYP3A4—Doxorubicin—kidney cancer	0.00486	0.0106	CbGbCtD
Granisetron—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000133	0.000802	CcSEcCtD
Granisetron—Gastrointestinal disorder—Vincristine—kidney cancer	0.000133	0.000802	CcSEcCtD
Granisetron—Rash—Erlotinib—kidney cancer	0.000132	0.000799	CcSEcCtD
Granisetron—Dermatitis—Erlotinib—kidney cancer	0.000132	0.000799	CcSEcCtD
Granisetron—Palpitations—Paclitaxel—kidney cancer	0.000132	0.000798	CcSEcCtD
Granisetron—Hyponatraemia—Doxorubicin—kidney cancer	0.000132	0.000797	CcSEcCtD
Granisetron—Insomnia—Gemcitabine—kidney cancer	0.000132	0.000797	CcSEcCtD
Granisetron—Headache—Erlotinib—kidney cancer	0.000131	0.000794	CcSEcCtD
Granisetron—Loss of consciousness—Paclitaxel—kidney cancer	0.000131	0.000794	CcSEcCtD
Granisetron—Constipation—Vincristine—kidney cancer	0.000131	0.000794	CcSEcCtD
Granisetron—Pain—Vincristine—kidney cancer	0.000131	0.000794	CcSEcCtD
Granisetron—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.000131	0.000794	CcSEcCtD
Granisetron—Paraesthesia—Gemcitabine—kidney cancer	0.000131	0.000791	CcSEcCtD
Granisetron—Flushing—Capecitabine—kidney cancer	0.000131	0.000791	CcSEcCtD
Granisetron—Cough—Paclitaxel—kidney cancer	0.00013	0.000788	CcSEcCtD
Granisetron—Asthenia—Sunitinib—kidney cancer	0.00013	0.000788	CcSEcCtD
Granisetron—Dyspnoea—Gemcitabine—kidney cancer	0.00013	0.000785	CcSEcCtD
Granisetron—Nausea—Vinblastine—kidney cancer	0.00013	0.000784	CcSEcCtD
Granisetron—Somnolence—Gemcitabine—kidney cancer	0.00013	0.000783	CcSEcCtD
Granisetron—Migraine—Doxorubicin—kidney cancer	0.000129	0.000781	CcSEcCtD
Granisetron—Nausea—Everolimus—kidney cancer	0.000129	0.000781	CcSEcCtD
Granisetron—Diarrhoea—Sorafenib—kidney cancer	0.000129	0.00078	CcSEcCtD
Granisetron—Hypertension—Paclitaxel—kidney cancer	0.000129	0.00078	CcSEcCtD
Granisetron—Pruritus—Sunitinib—kidney cancer	0.000128	0.000777	CcSEcCtD
Granisetron—Angiopathy—Capecitabine—kidney cancer	0.000128	0.000773	CcSEcCtD
Granisetron—Arthralgia—Paclitaxel—kidney cancer	0.000127	0.000769	CcSEcCtD
Granisetron—Chest pain—Paclitaxel—kidney cancer	0.000127	0.000769	CcSEcCtD
Granisetron—Anxiety—Paclitaxel—kidney cancer	0.000127	0.000767	CcSEcCtD
Granisetron—Decreased appetite—Gemcitabine—kidney cancer	0.000127	0.000766	CcSEcCtD
Granisetron—Hypersensitivity—Dactinomycin—kidney cancer	0.000127	0.000766	CcSEcCtD
Granisetron—Chills—Capecitabine—kidney cancer	0.000126	0.000764	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000126	0.000764	CcSEcCtD
Granisetron—Arrhythmia—Capecitabine—kidney cancer	0.000126	0.000761	CcSEcCtD
Granisetron—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000126	0.00076	CcSEcCtD
Granisetron—Discomfort—Paclitaxel—kidney cancer	0.000126	0.00076	CcSEcCtD
Granisetron—Gastrointestinal pain—Vincristine—kidney cancer	0.000126	0.000759	CcSEcCtD
Granisetron—Dizziness—Sorafenib—kidney cancer	0.000125	0.000754	CcSEcCtD
Granisetron—Pain—Gemcitabine—kidney cancer	0.000125	0.000753	CcSEcCtD
Granisetron—Constipation—Gemcitabine—kidney cancer	0.000125	0.000753	CcSEcCtD
Granisetron—Nausea—Erlotinib—kidney cancer	0.000125	0.000753	CcSEcCtD
Granisetron—Alopecia—Capecitabine—kidney cancer	0.000125	0.000753	CcSEcCtD
Granisetron—Dry mouth—Paclitaxel—kidney cancer	0.000124	0.000752	CcSEcCtD
Granisetron—Diarrhoea—Sunitinib—kidney cancer	0.000124	0.000751	CcSEcCtD
Granisetron—Asthenia—Dactinomycin—kidney cancer	0.000123	0.000746	CcSEcCtD
Granisetron—Malnutrition—Capecitabine—kidney cancer	0.000123	0.000741	CcSEcCtD
Granisetron—Anaphylactic shock—Paclitaxel—kidney cancer	0.000122	0.000737	CcSEcCtD
Granisetron—Oedema—Paclitaxel—kidney cancer	0.000122	0.000737	CcSEcCtD
Granisetron—Abdominal pain—Vincristine—kidney cancer	0.000121	0.000734	CcSEcCtD
Granisetron—Body temperature increased—Vincristine—kidney cancer	0.000121	0.000734	CcSEcCtD
Granisetron—Liver function test abnormal—Doxorubicin—kidney cancer	0.000121	0.000733	CcSEcCtD
Granisetron—Infection—Paclitaxel—kidney cancer	0.000121	0.000733	CcSEcCtD
Granisetron—Flatulence—Capecitabine—kidney cancer	0.000121	0.000731	CcSEcCtD
Granisetron—Dysgeusia—Capecitabine—kidney cancer	0.00012	0.000726	CcSEcCtD
Granisetron—Dizziness—Sunitinib—kidney cancer	0.00012	0.000726	CcSEcCtD
Granisetron—Feeling abnormal—Gemcitabine—kidney cancer	0.00012	0.000726	CcSEcCtD
Granisetron—Shock—Paclitaxel—kidney cancer	0.00012	0.000725	CcSEcCtD
Granisetron—Vomiting—Sorafenib—kidney cancer	0.00012	0.000725	CcSEcCtD
Granisetron—Orthostatic hypotension—Doxorubicin—kidney cancer	0.00012	0.000725	CcSEcCtD
Granisetron—Nervous system disorder—Paclitaxel—kidney cancer	0.00012	0.000723	CcSEcCtD
Granisetron—Hypokalaemia—Doxorubicin—kidney cancer	0.000119	0.000722	CcSEcCtD
Granisetron—Thrombocytopenia—Paclitaxel—kidney cancer	0.000119	0.000722	CcSEcCtD
Granisetron—Tachycardia—Paclitaxel—kidney cancer	0.000119	0.00072	CcSEcCtD
Granisetron—Rash—Sorafenib—kidney cancer	0.000119	0.000719	CcSEcCtD
Granisetron—Dermatitis—Sorafenib—kidney cancer	0.000119	0.000719	CcSEcCtD
Granisetron—Skin disorder—Paclitaxel—kidney cancer	0.000118	0.000716	CcSEcCtD
Granisetron—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000118	0.000715	CcSEcCtD
Granisetron—Headache—Sorafenib—kidney cancer	0.000118	0.000715	CcSEcCtD
Granisetron—Hyperhidrosis—Paclitaxel—kidney cancer	0.000118	0.000713	CcSEcCtD
Granisetron—Diarrhoea—Dactinomycin—kidney cancer	0.000118	0.000711	CcSEcCtD
Granisetron—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000116	0.0007	CcSEcCtD
Granisetron—Vomiting—Sunitinib—kidney cancer	0.000115	0.000698	CcSEcCtD
Granisetron—Body temperature increased—Gemcitabine—kidney cancer	0.000115	0.000696	CcSEcCtD
Granisetron—Tremor—Capecitabine—kidney cancer	0.000115	0.000695	CcSEcCtD
Granisetron—Rash—Sunitinib—kidney cancer	0.000114	0.000692	CcSEcCtD
Granisetron—Dermatitis—Sunitinib—kidney cancer	0.000114	0.000691	CcSEcCtD
Granisetron—Abdominal distension—Doxorubicin—kidney cancer	0.000114	0.000691	CcSEcCtD
Granisetron—Hypotension—Paclitaxel—kidney cancer	0.000114	0.000689	CcSEcCtD
Granisetron—Ill-defined disorder—Capecitabine—kidney cancer	0.000114	0.000688	CcSEcCtD
Granisetron—Headache—Sunitinib—kidney cancer	0.000114	0.000688	CcSEcCtD
Granisetron—Anaemia—Capecitabine—kidney cancer	0.000113	0.000685	CcSEcCtD
Granisetron—Hypersensitivity—Vincristine—kidney cancer	0.000113	0.000684	CcSEcCtD
Granisetron—Eosinophilia—Doxorubicin—kidney cancer	0.000112	0.000679	CcSEcCtD
Granisetron—Nausea—Sorafenib—kidney cancer	0.000112	0.000678	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000111	0.000672	CcSEcCtD
Granisetron—Malaise—Capecitabine—kidney cancer	0.000111	0.000669	CcSEcCtD
Granisetron—Angina pectoris—Doxorubicin—kidney cancer	0.000111	0.000668	CcSEcCtD
Granisetron—Insomnia—Paclitaxel—kidney cancer	0.00011	0.000667	CcSEcCtD
Granisetron—Vertigo—Capecitabine—kidney cancer	0.00011	0.000666	CcSEcCtD
Granisetron—Asthenia—Vincristine—kidney cancer	0.00011	0.000666	CcSEcCtD
Granisetron—Syncope—Capecitabine—kidney cancer	0.00011	0.000665	CcSEcCtD
Granisetron—Leukopenia—Capecitabine—kidney cancer	0.00011	0.000664	CcSEcCtD
Granisetron—Paraesthesia—Paclitaxel—kidney cancer	0.00011	0.000662	CcSEcCtD
Granisetron—Vomiting—Dactinomycin—kidney cancer	0.000109	0.000661	CcSEcCtD
Granisetron—Dyspnoea—Paclitaxel—kidney cancer	0.000109	0.000657	CcSEcCtD
Granisetron—Somnolence—Paclitaxel—kidney cancer	0.000108	0.000656	CcSEcCtD
Granisetron—Palpitations—Capecitabine—kidney cancer	0.000108	0.000655	CcSEcCtD
Granisetron—Rash—Dactinomycin—kidney cancer	0.000108	0.000655	CcSEcCtD
Granisetron—Nausea—Sunitinib—kidney cancer	0.000108	0.000652	CcSEcCtD
Granisetron—Loss of consciousness—Capecitabine—kidney cancer	0.000108	0.000652	CcSEcCtD
Granisetron—Dyspepsia—Paclitaxel—kidney cancer	0.000107	0.000649	CcSEcCtD
Granisetron—Cough—Capecitabine—kidney cancer	0.000107	0.000647	CcSEcCtD
Granisetron—Dysuria—Doxorubicin—kidney cancer	0.000106	0.000641	CcSEcCtD
Granisetron—Decreased appetite—Paclitaxel—kidney cancer	0.000106	0.000641	CcSEcCtD
Granisetron—Hypertension—Capecitabine—kidney cancer	0.000106	0.00064	CcSEcCtD
Granisetron—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000105	0.000637	CcSEcCtD
Granisetron—Diarrhoea—Vincristine—kidney cancer	0.000105	0.000635	CcSEcCtD
Granisetron—Asthenia—Gemcitabine—kidney cancer	0.000105	0.000632	CcSEcCtD
Granisetron—Arthralgia—Capecitabine—kidney cancer	0.000104	0.000631	CcSEcCtD
Granisetron—Chest pain—Capecitabine—kidney cancer	0.000104	0.000631	CcSEcCtD
Granisetron—Pain—Paclitaxel—kidney cancer	0.000104	0.000631	CcSEcCtD
Granisetron—Constipation—Paclitaxel—kidney cancer	0.000104	0.000631	CcSEcCtD
Granisetron—Anxiety—Capecitabine—kidney cancer	0.000104	0.000629	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000104	0.000627	CcSEcCtD
Granisetron—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000104	0.000626	CcSEcCtD
Granisetron—Discomfort—Capecitabine—kidney cancer	0.000103	0.000624	CcSEcCtD
Granisetron—Pruritus—Gemcitabine—kidney cancer	0.000103	0.000623	CcSEcCtD
Granisetron—Dry mouth—Capecitabine—kidney cancer	0.000102	0.000617	CcSEcCtD
Granisetron—Nausea—Dactinomycin—kidney cancer	0.000102	0.000617	CcSEcCtD
Granisetron—Dizziness—Vincristine—kidney cancer	0.000102	0.000614	CcSEcCtD
Granisetron—Feeling abnormal—Paclitaxel—kidney cancer	0.000101	0.000608	CcSEcCtD
Granisetron—Oedema—Capecitabine—kidney cancer	0.0001	0.000605	CcSEcCtD
Granisetron—Gastrointestinal pain—Paclitaxel—kidney cancer	9.98e-05	0.000603	CcSEcCtD
Granisetron—Diarrhoea—Gemcitabine—kidney cancer	9.97e-05	0.000603	CcSEcCtD
Granisetron—Infection—Capecitabine—kidney cancer	9.95e-05	0.000601	CcSEcCtD
Granisetron—Jaundice—Doxorubicin—kidney cancer	9.86e-05	0.000596	CcSEcCtD
Granisetron—Shock—Capecitabine—kidney cancer	9.85e-05	0.000595	CcSEcCtD
Granisetron—Urinary tract infection—Doxorubicin—kidney cancer	9.83e-05	0.000594	CcSEcCtD
Granisetron—Nervous system disorder—Capecitabine—kidney cancer	9.82e-05	0.000593	CcSEcCtD
Granisetron—Thrombocytopenia—Capecitabine—kidney cancer	9.8e-05	0.000592	CcSEcCtD
Granisetron—Tachycardia—Capecitabine—kidney cancer	9.77e-05	0.000591	CcSEcCtD
Granisetron—Vomiting—Vincristine—kidney cancer	9.77e-05	0.00059	CcSEcCtD
Granisetron—Skin disorder—Capecitabine—kidney cancer	9.72e-05	0.000588	CcSEcCtD
Granisetron—Sweating—Doxorubicin—kidney cancer	9.7e-05	0.000586	CcSEcCtD
Granisetron—Urticaria—Paclitaxel—kidney cancer	9.69e-05	0.000586	CcSEcCtD
Granisetron—Rash—Vincristine—kidney cancer	9.68e-05	0.000585	CcSEcCtD
Granisetron—Hyperhidrosis—Capecitabine—kidney cancer	9.68e-05	0.000585	CcSEcCtD
Granisetron—Dermatitis—Vincristine—kidney cancer	9.67e-05	0.000585	CcSEcCtD
Granisetron—Abdominal pain—Paclitaxel—kidney cancer	9.64e-05	0.000583	CcSEcCtD
Granisetron—Body temperature increased—Paclitaxel—kidney cancer	9.64e-05	0.000583	CcSEcCtD
Granisetron—Headache—Vincristine—kidney cancer	9.62e-05	0.000582	CcSEcCtD
Granisetron—Hepatobiliary disease—Doxorubicin—kidney cancer	9.57e-05	0.000578	CcSEcCtD
Granisetron—Epistaxis—Doxorubicin—kidney cancer	9.54e-05	0.000577	CcSEcCtD
Granisetron—Sinusitis—Doxorubicin—kidney cancer	9.49e-05	0.000574	CcSEcCtD
Granisetron—Hypotension—Capecitabine—kidney cancer	9.35e-05	0.000565	CcSEcCtD
Granisetron—Vomiting—Gemcitabine—kidney cancer	9.26e-05	0.00056	CcSEcCtD
Granisetron—Bradycardia—Doxorubicin—kidney cancer	9.25e-05	0.000559	CcSEcCtD
Granisetron—Rash—Gemcitabine—kidney cancer	9.19e-05	0.000555	CcSEcCtD
Granisetron—Dermatitis—Gemcitabine—kidney cancer	9.18e-05	0.000555	CcSEcCtD
Granisetron—Headache—Gemcitabine—kidney cancer	9.13e-05	0.000552	CcSEcCtD
Granisetron—Nausea—Vincristine—kidney cancer	9.12e-05	0.000551	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Capecitabine—kidney cancer	9.12e-05	0.000551	CcSEcCtD
Granisetron—Rhinitis—Doxorubicin—kidney cancer	9.11e-05	0.00055	CcSEcCtD
Granisetron—Insomnia—Capecitabine—kidney cancer	9.05e-05	0.000547	CcSEcCtD
Granisetron—Paraesthesia—Capecitabine—kidney cancer	8.99e-05	0.000543	CcSEcCtD
Granisetron—Hypersensitivity—Paclitaxel—kidney cancer	8.99e-05	0.000543	CcSEcCtD
Granisetron—Connective tissue disorder—Doxorubicin—kidney cancer	8.93e-05	0.00054	CcSEcCtD
Granisetron—Dyspnoea—Capecitabine—kidney cancer	8.92e-05	0.00054	CcSEcCtD
Granisetron—Dyspepsia—Capecitabine—kidney cancer	8.81e-05	0.000533	CcSEcCtD
Granisetron—Visual impairment—Doxorubicin—kidney cancer	8.75e-05	0.000529	CcSEcCtD
Granisetron—Asthenia—Paclitaxel—kidney cancer	8.75e-05	0.000529	CcSEcCtD
Granisetron—Decreased appetite—Capecitabine—kidney cancer	8.7e-05	0.000526	CcSEcCtD
Granisetron—Nausea—Gemcitabine—kidney cancer	8.65e-05	0.000523	CcSEcCtD
Granisetron—Gastrointestinal disorder—Capecitabine—kidney cancer	8.64e-05	0.000522	CcSEcCtD
Granisetron—Pruritus—Paclitaxel—kidney cancer	8.63e-05	0.000522	CcSEcCtD
Granisetron—Pain—Capecitabine—kidney cancer	8.56e-05	0.000517	CcSEcCtD
Granisetron—Constipation—Capecitabine—kidney cancer	8.56e-05	0.000517	CcSEcCtD
Granisetron—Flushing—Doxorubicin—kidney cancer	8.43e-05	0.00051	CcSEcCtD
Granisetron—Diarrhoea—Paclitaxel—kidney cancer	8.35e-05	0.000505	CcSEcCtD
Granisetron—Feeling abnormal—Capecitabine—kidney cancer	8.25e-05	0.000499	CcSEcCtD
Granisetron—Angiopathy—Doxorubicin—kidney cancer	8.24e-05	0.000498	CcSEcCtD
Granisetron—Gastrointestinal pain—Capecitabine—kidney cancer	8.19e-05	0.000495	CcSEcCtD
Granisetron—Chills—Doxorubicin—kidney cancer	8.15e-05	0.000493	CcSEcCtD
Granisetron—Arrhythmia—Doxorubicin—kidney cancer	8.11e-05	0.00049	CcSEcCtD
Granisetron—Dizziness—Paclitaxel—kidney cancer	8.07e-05	0.000488	CcSEcCtD
Granisetron—Alopecia—Doxorubicin—kidney cancer	8.03e-05	0.000485	CcSEcCtD
Granisetron—Urticaria—Capecitabine—kidney cancer	7.95e-05	0.000481	CcSEcCtD
Granisetron—Abdominal pain—Capecitabine—kidney cancer	7.91e-05	0.000478	CcSEcCtD
Granisetron—Body temperature increased—Capecitabine—kidney cancer	7.91e-05	0.000478	CcSEcCtD
Granisetron—Malnutrition—Doxorubicin—kidney cancer	7.91e-05	0.000478	CcSEcCtD
Granisetron—Flatulence—Doxorubicin—kidney cancer	7.79e-05	0.000471	CcSEcCtD
Granisetron—Tension—Doxorubicin—kidney cancer	7.76e-05	0.000469	CcSEcCtD
Granisetron—Vomiting—Paclitaxel—kidney cancer	7.76e-05	0.000469	CcSEcCtD
Granisetron—Dysgeusia—Doxorubicin—kidney cancer	7.74e-05	0.000468	CcSEcCtD
Granisetron—Rash—Paclitaxel—kidney cancer	7.69e-05	0.000465	CcSEcCtD
Granisetron—Dermatitis—Paclitaxel—kidney cancer	7.68e-05	0.000465	CcSEcCtD
Granisetron—Nervousness—Doxorubicin—kidney cancer	7.68e-05	0.000464	CcSEcCtD
Granisetron—Headache—Paclitaxel—kidney cancer	7.64e-05	0.000462	CcSEcCtD
Granisetron—CYP2D6—Xenobiotics—CYP1A1—kidney cancer	7.57e-05	0.00801	CbGpPWpGaD
Granisetron—CYP1A1—Arachidonic acid metabolism—PTGS1—kidney cancer	7.5e-05	0.00793	CbGpPWpGaD
Granisetron—Hypersensitivity—Capecitabine—kidney cancer	7.38e-05	0.000446	CcSEcCtD
Granisetron—Ill-defined disorder—Doxorubicin—kidney cancer	7.34e-05	0.000443	CcSEcCtD
Granisetron—Anaemia—Doxorubicin—kidney cancer	7.31e-05	0.000442	CcSEcCtD
Granisetron—CYP2D6—Tamoxifen metabolism—CYP1A1—kidney cancer	7.28e-05	0.0077	CbGpPWpGaD
Granisetron—Agitation—Doxorubicin—kidney cancer	7.27e-05	0.000439	CcSEcCtD
Granisetron—Nausea—Paclitaxel—kidney cancer	7.25e-05	0.000438	CcSEcCtD
Granisetron—CYP2D6—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	7.18e-05	0.0076	CbGpPWpGaD
Granisetron—Asthenia—Capecitabine—kidney cancer	7.18e-05	0.000434	CcSEcCtD
Granisetron—CYP3A4—Tryptophan metabolism—ALDH1A1—kidney cancer	7.16e-05	0.00758	CbGpPWpGaD
Granisetron—Malaise—Doxorubicin—kidney cancer	7.13e-05	0.000431	CcSEcCtD
Granisetron—Vertigo—Doxorubicin—kidney cancer	7.1e-05	0.000429	CcSEcCtD
Granisetron—Syncope—Doxorubicin—kidney cancer	7.09e-05	0.000429	CcSEcCtD
Granisetron—Pruritus—Capecitabine—kidney cancer	7.08e-05	0.000428	CcSEcCtD
Granisetron—Leukopenia—Doxorubicin—kidney cancer	7.08e-05	0.000428	CcSEcCtD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUNB—kidney cancer	7.06e-05	0.00747	CbGpPWpGaD
Granisetron—Palpitations—Doxorubicin—kidney cancer	6.99e-05	0.000422	CcSEcCtD
Granisetron—CYP2D6—Biological oxidations—ACY1—kidney cancer	6.96e-05	0.00737	CbGpPWpGaD
Granisetron—Loss of consciousness—Doxorubicin—kidney cancer	6.95e-05	0.00042	CcSEcCtD
Granisetron—Cough—Doxorubicin—kidney cancer	6.9e-05	0.000417	CcSEcCtD
Granisetron—Diarrhoea—Capecitabine—kidney cancer	6.85e-05	0.000414	CcSEcCtD
Granisetron—Hypertension—Doxorubicin—kidney cancer	6.83e-05	0.000413	CcSEcCtD
Granisetron—Arthralgia—Doxorubicin—kidney cancer	6.73e-05	0.000407	CcSEcCtD
Granisetron—Chest pain—Doxorubicin—kidney cancer	6.73e-05	0.000407	CcSEcCtD
Granisetron—Anxiety—Doxorubicin—kidney cancer	6.71e-05	0.000406	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	6.68e-05	0.000404	CcSEcCtD
Granisetron—Discomfort—Doxorubicin—kidney cancer	6.65e-05	0.000402	CcSEcCtD
Granisetron—Dizziness—Capecitabine—kidney cancer	6.62e-05	0.0004	CcSEcCtD
Granisetron—Dry mouth—Doxorubicin—kidney cancer	6.58e-05	0.000398	CcSEcCtD
Granisetron—Anaphylactic shock—Doxorubicin—kidney cancer	6.45e-05	0.00039	CcSEcCtD
Granisetron—Oedema—Doxorubicin—kidney cancer	6.45e-05	0.00039	CcSEcCtD
Granisetron—Infection—Doxorubicin—kidney cancer	6.41e-05	0.000388	CcSEcCtD
Granisetron—Vomiting—Capecitabine—kidney cancer	6.36e-05	0.000385	CcSEcCtD
Granisetron—Shock—Doxorubicin—kidney cancer	6.35e-05	0.000384	CcSEcCtD
Granisetron—Nervous system disorder—Doxorubicin—kidney cancer	6.33e-05	0.000383	CcSEcCtD
Granisetron—Thrombocytopenia—Doxorubicin—kidney cancer	6.32e-05	0.000382	CcSEcCtD
Granisetron—Rash—Capecitabine—kidney cancer	6.31e-05	0.000382	CcSEcCtD
Granisetron—Dermatitis—Capecitabine—kidney cancer	6.31e-05	0.000381	CcSEcCtD
Granisetron—Tachycardia—Doxorubicin—kidney cancer	6.3e-05	0.000381	CcSEcCtD
Granisetron—Headache—Capecitabine—kidney cancer	6.27e-05	0.000379	CcSEcCtD
Granisetron—Skin disorder—Doxorubicin—kidney cancer	6.27e-05	0.000379	CcSEcCtD
Granisetron—Hyperhidrosis—Doxorubicin—kidney cancer	6.24e-05	0.000377	CcSEcCtD
Granisetron—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—GLIPR1—kidney cancer	6.18e-05	0.00654	CbGpPWpGaD
Granisetron—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	6.13e-05	0.00648	CbGpPWpGaD
Granisetron—Hypotension—Doxorubicin—kidney cancer	6.03e-05	0.000364	CcSEcCtD
Granisetron—HTR3A—Transmembrane transport of small molecules—ATP7B—kidney cancer	6e-05	0.00635	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—ANXA2—kidney cancer	6e-05	0.00635	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—SLC5A3—kidney cancer	6e-05	0.00635	CbGpPWpGaD
Granisetron—Nausea—Capecitabine—kidney cancer	5.95e-05	0.000359	CcSEcCtD
Granisetron—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	5.92e-05	0.00626	CbGpPWpGaD
Granisetron—Musculoskeletal discomfort—Doxorubicin—kidney cancer	5.88e-05	0.000355	CcSEcCtD
Granisetron—HTR3A—SIDS Susceptibility Pathways—HIF1A—kidney cancer	5.84e-05	0.00618	CbGpPWpGaD
Granisetron—Insomnia—Doxorubicin—kidney cancer	5.84e-05	0.000353	CcSEcCtD
Granisetron—Paraesthesia—Doxorubicin—kidney cancer	5.79e-05	0.00035	CcSEcCtD
Granisetron—Dyspnoea—Doxorubicin—kidney cancer	5.75e-05	0.000348	CcSEcCtD
Granisetron—Somnolence—Doxorubicin—kidney cancer	5.74e-05	0.000347	CcSEcCtD
Granisetron—CYP3A4—Estrogen metabolism—GSTM1—kidney cancer	5.68e-05	0.00601	CbGpPWpGaD
Granisetron—Dyspepsia—Doxorubicin—kidney cancer	5.68e-05	0.000343	CcSEcCtD
Granisetron—CYP2D6—Melatonin metabolism and effects—CYP1A1—kidney cancer	5.62e-05	0.00595	CbGpPWpGaD
Granisetron—Decreased appetite—Doxorubicin—kidney cancer	5.61e-05	0.000339	CcSEcCtD
Granisetron—Gastrointestinal disorder—Doxorubicin—kidney cancer	5.57e-05	0.000337	CcSEcCtD
Granisetron—CYP3A5—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	5.56e-05	0.00588	CbGpPWpGaD
Granisetron—Pain—Doxorubicin—kidney cancer	5.52e-05	0.000334	CcSEcCtD
Granisetron—Constipation—Doxorubicin—kidney cancer	5.52e-05	0.000334	CcSEcCtD
Granisetron—CYP3A4—Estrogen metabolism—CYP1A1—kidney cancer	5.39e-05	0.0057	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—ALDH1A1—kidney cancer	5.37e-05	0.00568	CbGpPWpGaD
Granisetron—Feeling abnormal—Doxorubicin—kidney cancer	5.32e-05	0.000321	CcSEcCtD
Granisetron—Gastrointestinal pain—Doxorubicin—kidney cancer	5.28e-05	0.000319	CcSEcCtD
Granisetron—CYP1A1—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	5.25e-05	0.00556	CbGpPWpGaD
Granisetron—CYP3A4—Irinotecan Pathway—APC—kidney cancer	5.16e-05	0.00546	CbGpPWpGaD
Granisetron—Urticaria—Doxorubicin—kidney cancer	5.13e-05	0.00031	CcSEcCtD
Granisetron—Abdominal pain—Doxorubicin—kidney cancer	5.1e-05	0.000308	CcSEcCtD
Granisetron—Body temperature increased—Doxorubicin—kidney cancer	5.1e-05	0.000308	CcSEcCtD
Granisetron—CYP1A1—Biological oxidations—ALDH1A1—kidney cancer	5.07e-05	0.00536	CbGpPWpGaD
Granisetron—CYP3A4—Xenobiotics—CYP1A1—kidney cancer	4.95e-05	0.00524	CbGpPWpGaD
Granisetron—CYP3A4—Tamoxifen metabolism—CYP1A1—kidney cancer	4.76e-05	0.00504	CbGpPWpGaD
Granisetron—Hypersensitivity—Doxorubicin—kidney cancer	4.75e-05	0.000287	CcSEcCtD
Granisetron—CYP3A4—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	4.7e-05	0.00497	CbGpPWpGaD
Granisetron—Asthenia—Doxorubicin—kidney cancer	4.63e-05	0.00028	CcSEcCtD
Granisetron—Pruritus—Doxorubicin—kidney cancer	4.57e-05	0.000276	CcSEcCtD
Granisetron—CYP3A4—Biological oxidations—ACY1—kidney cancer	4.55e-05	0.00482	CbGpPWpGaD
Granisetron—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	4.42e-05	0.00468	CbGpPWpGaD
Granisetron—Diarrhoea—Doxorubicin—kidney cancer	4.42e-05	0.000267	CcSEcCtD
Granisetron—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	4.36e-05	0.00462	CbGpPWpGaD
Granisetron—Dizziness—Doxorubicin—kidney cancer	4.27e-05	0.000258	CcSEcCtD
Granisetron—Vomiting—Doxorubicin—kidney cancer	4.1e-05	0.000248	CcSEcCtD
Granisetron—Rash—Doxorubicin—kidney cancer	4.07e-05	0.000246	CcSEcCtD
Granisetron—Dermatitis—Doxorubicin—kidney cancer	4.06e-05	0.000246	CcSEcCtD
Granisetron—Headache—Doxorubicin—kidney cancer	4.04e-05	0.000244	CcSEcCtD
Granisetron—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	3.96e-05	0.00418	CbGpPWpGaD
Granisetron—HTR3A—Ion channel transport—RAF1—kidney cancer	3.92e-05	0.00415	CbGpPWpGaD
Granisetron—Nausea—Doxorubicin—kidney cancer	3.83e-05	0.000232	CcSEcCtD
Granisetron—CYP2D6—Biological oxidations—ALDH1A1—kidney cancer	3.82e-05	0.00404	CbGpPWpGaD
Granisetron—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	3.69e-05	0.00391	CbGpPWpGaD
Granisetron—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	3.58e-05	0.00379	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—JUN—kidney cancer	3.52e-05	0.00373	CbGpPWpGaD
Granisetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	3.52e-05	0.00372	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	3.5e-05	0.0037	CbGpPWpGaD
Granisetron—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—kidney cancer	3.39e-05	0.00358	CbGpPWpGaD
Granisetron—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	3.3e-05	0.00349	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—RAF1—kidney cancer	3.18e-05	0.00336	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.16e-05	0.00335	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—RELA—kidney cancer	3.16e-05	0.00335	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—GSTT1—kidney cancer	3.15e-05	0.00334	CbGpPWpGaD
Granisetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	3.14e-05	0.00333	CbGpPWpGaD
Granisetron—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	3.11e-05	0.00329	CbGpPWpGaD
Granisetron—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	3.1e-05	0.00328	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—VEGFA—kidney cancer	3.08e-05	0.00326	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—kidney cancer	3.07e-05	0.00325	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.06e-05	0.00323	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—GSTT1—kidney cancer	2.98e-05	0.00315	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—PTGS1—kidney cancer	2.95e-05	0.00313	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—kidney cancer	2.91e-05	0.00308	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—kidney cancer	2.91e-05	0.00308	CbGpPWpGaD
Granisetron—CYP1A1—Arachidonic acid metabolism—PTGS2—kidney cancer	2.87e-05	0.00304	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—kidney cancer	2.85e-05	0.00301	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—PTGS1—kidney cancer	2.79e-05	0.00295	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—kidney cancer	2.77e-05	0.00293	CbGpPWpGaD
Granisetron—CYP3A5—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.67e-05	0.00283	CbGpPWpGaD
Granisetron—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	2.59e-05	0.00274	CbGpPWpGaD
Granisetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	2.55e-05	0.0027	CbGpPWpGaD
Granisetron—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	2.54e-05	0.00269	CbGpPWpGaD
Granisetron—CYP1A1—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.52e-05	0.00267	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	2.49e-05	0.00264	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	2.46e-05	0.00261	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	2.42e-05	0.00256	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.41e-05	0.00255	CbGpPWpGaD
Granisetron—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	2.34e-05	0.00248	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—GSTT1—kidney cancer	2.24e-05	0.00237	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—MYC—kidney cancer	2.23e-05	0.00236	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—GSTP1—kidney cancer	2.19e-05	0.00231	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	2.18e-05	0.0023	CbGpPWpGaD
Granisetron—CYP3A5—Metapathway biotransformation—GSTP1—kidney cancer	2.16e-05	0.00228	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—PTGS1—kidney cancer	2.1e-05	0.00222	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—GSTP1—kidney cancer	2.06e-05	0.00218	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	2.06e-05	0.00218	CbGpPWpGaD
Granisetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	2.06e-05	0.00217	CbGpPWpGaD
Granisetron—CYP1A1—Metapathway biotransformation—GSTP1—kidney cancer	2.04e-05	0.00215	CbGpPWpGaD
Granisetron—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	2.03e-05	0.00215	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—GSTM1—kidney cancer	2.01e-05	0.00212	CbGpPWpGaD
Granisetron—CYP3A5—Metapathway biotransformation—GSTM1—kidney cancer	1.98e-05	0.0021	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—CYP1A1—kidney cancer	1.9e-05	0.00201	CbGpPWpGaD
Granisetron—CYP2D6—Phase 1 - Functionalization of compounds—POMC—kidney cancer	1.9e-05	0.00201	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—GSTM1—kidney cancer	1.9e-05	0.00201	CbGpPWpGaD
Granisetron—CYP3A5—Metapathway biotransformation—CYP1A1—kidney cancer	1.88e-05	0.00199	CbGpPWpGaD
Granisetron—CYP1A1—Metapathway biotransformation—GSTM1—kidney cancer	1.87e-05	0.00198	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ACY1—kidney cancer	1.67e-05	0.00177	CbGpPWpGaD
Granisetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	1.67e-05	0.00176	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ACY1—kidney cancer	1.58e-05	0.00167	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—GSTP1—kidney cancer	1.55e-05	0.00164	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—GSTP1—kidney cancer	1.53e-05	0.00162	CbGpPWpGaD
Granisetron—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	1.53e-05	0.00162	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—GSTT1—kidney cancer	1.47e-05	0.00155	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—GSTM1—kidney cancer	1.43e-05	0.00151	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PDHB—kidney cancer	1.42e-05	0.00151	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—POMC—kidney cancer	1.42e-05	0.0015	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—GSTM1—kidney cancer	1.41e-05	0.00149	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—PTGS1—kidney cancer	1.37e-05	0.00145	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—RAF1—kidney cancer	1.36e-05	0.00144	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—CYP1A1—kidney cancer	1.35e-05	0.00143	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.35e-05	0.00143	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PDHB—kidney cancer	1.35e-05	0.00142	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—POMC—kidney cancer	1.34e-05	0.00142	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CCBL1—kidney cancer	1.34e-05	0.00142	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—CYP1A1—kidney cancer	1.34e-05	0.00141	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CCBL1—kidney cancer	1.26e-05	0.00134	CbGpPWpGaD
Granisetron—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	1.24e-05	0.00131	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ACY1—kidney cancer	1.19e-05	0.00126	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GLIPR1—kidney cancer	1.16e-05	0.00123	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PPAT—kidney cancer	1.16e-05	0.00123	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.14e-05	0.00121	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GLIPR1—kidney cancer	1.1e-05	0.00116	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PPAT—kidney cancer	1.1e-05	0.00116	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.08e-05	0.00115	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—FH—kidney cancer	1.08e-05	0.00114	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—APRT—kidney cancer	1.08e-05	0.00114	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.07e-05	0.00113	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—APRT—kidney cancer	1.02e-05	0.00108	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—FH—kidney cancer	1.02e-05	0.00108	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—GSTP1—kidney cancer	1.02e-05	0.00107	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GPC3—kidney cancer	1.01e-05	0.00107	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PDHB—kidney cancer	1.01e-05	0.00107	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—POMC—kidney cancer	1.01e-05	0.00107	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	1e-05	0.00106	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	9.96e-06	0.00105	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CA2—kidney cancer	9.87e-06	0.00104	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ALAD—kidney cancer	9.62e-06	0.00102	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GPC3—kidney cancer	9.59e-06	0.00101	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CCBL1—kidney cancer	9.52e-06	0.00101	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ST3GAL2—kidney cancer	9.39e-06	0.000993	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—GSTM1—kidney cancer	9.34e-06	0.000988	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CA2—kidney cancer	9.32e-06	0.000987	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	9.21e-06	0.000974	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ALDH1A1—kidney cancer	9.18e-06	0.000971	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ALAD—kidney cancer	9.09e-06	0.000961	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ST3GAL2—kidney cancer	8.87e-06	0.000938	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	8.85e-06	0.000936	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PGK1—kidney cancer	8.8e-06	0.000931	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—SLC5A3—kidney cancer	8.8e-06	0.000931	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	8.73e-06	0.000924	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ALDH1A1—kidney cancer	8.67e-06	0.000917	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—LDHB—kidney cancer	8.63e-06	0.000913	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—SLC5A3—kidney cancer	8.31e-06	0.000879	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PGK1—kidney cancer	8.31e-06	0.000879	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PPAT—kidney cancer	8.25e-06	0.000873	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GLIPR1—kidney cancer	8.25e-06	0.000873	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—LDHB—kidney cancer	8.15e-06	0.000862	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ACY1—kidney cancer	7.79e-06	0.000824	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—APRT—kidney cancer	7.67e-06	0.000812	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—FH—kidney cancer	7.67e-06	0.000812	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CA9—kidney cancer	7.48e-06	0.000791	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GPC3—kidney cancer	7.21e-06	0.000763	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CA9—kidney cancer	7.07e-06	0.000748	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CA2—kidney cancer	7.02e-06	0.000743	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ALAD—kidney cancer	6.84e-06	0.000724	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ST3GAL2—kidney cancer	6.68e-06	0.000706	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PDHB—kidney cancer	6.62e-06	0.0007	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—POMC—kidney cancer	6.6e-06	0.000698	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ALDH1A1—kidney cancer	6.52e-06	0.00069	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CRABP1—kidney cancer	6.36e-06	0.000673	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PGK1—kidney cancer	6.26e-06	0.000662	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—SLC5A3—kidney cancer	6.26e-06	0.000662	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CCBL1—kidney cancer	6.22e-06	0.000659	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—LDHB—kidney cancer	6.13e-06	0.000649	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CRABP1—kidney cancer	6.01e-06	0.000636	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ITPR2—kidney cancer	5.91e-06	0.000626	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ITPR2—kidney cancer	5.59e-06	0.000591	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GLIPR1—kidney cancer	5.4e-06	0.000571	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PPAT—kidney cancer	5.4e-06	0.000571	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ACHE—kidney cancer	5.39e-06	0.00057	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GSTT1—kidney cancer	5.39e-06	0.00057	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CA9—kidney cancer	5.32e-06	0.000563	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.15e-06	0.000545	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—SCARB1—kidney cancer	5.1e-06	0.00054	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GSTT1—kidney cancer	5.09e-06	0.000539	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ACHE—kidney cancer	5.09e-06	0.000539	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PTGS1—kidney cancer	5.05e-06	0.000535	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—APRT—kidney cancer	5.02e-06	0.000531	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—FH—kidney cancer	5.02e-06	0.000531	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PSMD7—kidney cancer	4.96e-06	0.000524	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—SCARB1—kidney cancer	4.82e-06	0.00051	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PTGS1—kidney cancer	4.77e-06	0.000505	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GPC3—kidney cancer	4.72e-06	0.000499	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—BCHE—kidney cancer	4.7e-06	0.000497	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PSMD7—kidney cancer	4.68e-06	0.000495	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—SLC5A5—kidney cancer	4.64e-06	0.000491	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CA2—kidney cancer	4.59e-06	0.000485	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CRABP1—kidney cancer	4.52e-06	0.000478	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—SLC2A1—kidney cancer	4.48e-06	0.000474	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ALAD—kidney cancer	4.47e-06	0.000473	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—BCHE—kidney cancer	4.44e-06	0.00047	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—SLC5A5—kidney cancer	4.38e-06	0.000464	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ST3GAL2—kidney cancer	4.36e-06	0.000462	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ALDH1A1—kidney cancer	4.27e-06	0.000451	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—SLC2A1—kidney cancer	4.23e-06	0.000448	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ITPR2—kidney cancer	4.2e-06	0.000445	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.11e-06	0.000435	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PGK1—kidney cancer	4.09e-06	0.000433	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—SLC5A3—kidney cancer	4.09e-06	0.000433	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—LDHB—kidney cancer	4.01e-06	0.000424	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GSTT1—kidney cancer	3.83e-06	0.000406	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ACHE—kidney cancer	3.83e-06	0.000406	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GSTP1—kidney cancer	3.74e-06	0.000395	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—SCARB1—kidney cancer	3.63e-06	0.000384	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PTGS1—kidney cancer	3.59e-06	0.00038	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.58e-06	0.000379	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ABCB1—kidney cancer	3.54e-06	0.000374	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GSTP1—kidney cancer	3.53e-06	0.000374	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PSMD7—kidney cancer	3.52e-06	0.000373	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CA9—kidney cancer	3.48e-06	0.000368	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GSTM1—kidney cancer	3.43e-06	0.000363	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ABCB1—kidney cancer	3.34e-06	0.000354	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—BCHE—kidney cancer	3.34e-06	0.000353	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—SLC5A5—kidney cancer	3.3e-06	0.000349	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CYP1A1—kidney cancer	3.26e-06	0.000344	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GSTM1—kidney cancer	3.24e-06	0.000343	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—SLC2A1—kidney cancer	3.19e-06	0.000337	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CRABP1—kidney cancer	2.96e-06	0.000313	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ITPR2—kidney cancer	2.75e-06	0.000291	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GSTP1—kidney cancer	2.66e-06	0.000281	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.53e-06	0.000267	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ABCB1—kidney cancer	2.52e-06	0.000266	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GSTT1—kidney cancer	2.51e-06	0.000265	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ACHE—kidney cancer	2.51e-06	0.000265	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GSTM1—kidney cancer	2.44e-06	0.000258	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—POMC—kidney cancer	2.43e-06	0.000257	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—SCARB1—kidney cancer	2.37e-06	0.000251	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PTGS1—kidney cancer	2.35e-06	0.000249	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CYP1A1—kidney cancer	2.32e-06	0.000245	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PSMD7—kidney cancer	2.3e-06	0.000244	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—POMC—kidney cancer	2.29e-06	0.000243	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—BCHE—kidney cancer	2.18e-06	0.000231	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.16e-06	0.000228	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.08e-06	0.00022	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PTGS2—kidney cancer	1.94e-06	0.000205	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PTGS2—kidney cancer	1.83e-06	0.000194	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GSTP1—kidney cancer	1.74e-06	0.000184	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—POMC—kidney cancer	1.73e-06	0.000183	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PTEN—kidney cancer	1.69e-06	0.000179	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ABCB1—kidney cancer	1.64e-06	0.000174	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GSTM1—kidney cancer	1.6e-06	0.000169	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PTEN—kidney cancer	1.6e-06	0.000169	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.51e-06	0.00016	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PTGS2—kidney cancer	1.38e-06	0.000146	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PTEN—kidney cancer	1.2e-06	0.000127	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PIK3CA—kidney cancer	1.19e-06	0.000126	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—POMC—kidney cancer	1.13e-06	0.000119	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PIK3CA—kidney cancer	1.13e-06	0.000119	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PTGS2—kidney cancer	9e-07	9.52e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PIK3CA—kidney cancer	8.47e-07	8.96e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PTEN—kidney cancer	7.85e-07	8.31e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PIK3CA—kidney cancer	5.54e-07	5.86e-05	CbGpPWpGaD
